Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
This study investigates the CCR7 chemokine receptor's prognostic value in gastric cancer and its relationship to metastasis. Normal and adjacent tumor cells in 70 patients with gastric cancer were evaluated for CCR7 expression using immunohistochemical staining. The prognostic values of high and low levels of expression of CCR7 were also evaluated by multivariate and univariate analyses. Analysis indicated high expression of CCR7 in 52.9% of tumor tissue. Moreover, high expression of CCR7 was significantly related to metastasis of lymph nodes (p = 0.00). In addition, high expression of CCR7 had a positive correlation to the disease stage (p = 0.00), age of ≥50 years (p = 0.019), male gender (p = 0.024), vascular involvement (p = 0.009), histology of tumor adenocarcinoma (p = 0.00), and poor tumor differentiation (p = 0.00). However, the high expression of the CCR7 marker was not related to the tumor size. Based on our results, CCR7 expression in gastric cancer can be considered a clinical prognostic indicator in patients with gastric cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10700099 | PMC |
| http://dx.doi.org/10.18502/ijhoscr.v17i4.13918 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expression analysis of C-FOS and XRCC3 Thr241Met polymorphism in gastric cancer.
Cell Mol Biol (Noisy-le-grand)
September 2025
Department of Biology, College of Education for Pure Sciences, University of Kerbala, Kerbala, Iraq.
Gastric cancer is one of the causes of deaths related to cancer across the globe and both genetic and environmental factors are the most prominent. Causes of its pathogenesis. This paper researches the expression of the C-FOS gene.
View Article and Find Full Text PDFConsiderations on the application of enhanced recovery after surgery (ERAS) in the perioperative management of gastric cancer.
Int J Surg
September 2025
Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China.
Brucine Inhibits Gastric Cancer via Activation of Ferroptosis Through Regulating the NF-κB Signaling Pathway.
J Biochem Mol Toxicol
September 2025
Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, 410011, PR China.
Gastric cancer (GC) is the third leading cause of cancer mortality globally, often presenting with insidious symptoms that lead to late-stage diagnoses, underscoring the critical need for innovative diagnostic and therapeutic strategies. One such avenue is the exploration of ferroptosis, a regulated form of cell death implicated in various pathological conditions and malignancies. In this study, we demonstrate that brucine, an alkaloid derived from Strychnos nux-vomica, exerts significant antitumor effects on GC cells both in vitro and in vivo.
View Article and Find Full Text PDFGastric metastasis arising from invasive ductal and mucinous carcinoma of the breast: a case report and literature review.
Front Oncol
August 2025
Information Technology Management, The Affiliated Hospital of Qingdao University, Qingdao, China.
Gastric metastasis of breast cancer is rare, and clinical data on its treatment and prognosis are limited at present. Herein, we report a case of gastric metastasis arising from invasive ductal and mucinous carcinoma of the breast and review the literature. A 51-year-old woman was diagnosed with infiltrating and mucinous carcinoma of the right breast accompanied by ipsilateral axillary lymph node and subclavian lymph node metastases.
View Article and Find Full Text PDFCorrection: Icariside II inhibits gastric cancer progression by suppressing the Wnt/β-catenin signaling pathway.
Cytotechnology
October 2025
Department of Pathology, Affiliated Hospital of Nantong University, Nantong, 226001 China.
[This corrects the article DOI: 10.1007/s10616-025-00761-3.].
View Article and Find Full Text PDF